Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cypress Bioscience Posts Wider 3Q Loss

November 10, 2010 10:06 am | News | Comments

Cypress Bioscience Inc. reported a larger fiscal third-quarter loss Tuesday after it licensed a series of new drug candidates as part of its plan to focus on treatments for central nervous system disorders.

US Says Proportion of Attention Deficit Kids Up

November 10, 2010 10:04 am | News | Comments

Health officials say ADHD is becoming more common in the U.S. The latest study says nearly 1 in 10 children ages 4 through 17 has been diagnosed with it.

DOJ Charges Former Glaxo Lawyer with Obstruction

November 10, 2010 10:01 am | News | Comments

Federal prosecutors said Tuesday they have charged a former GlaxoSmithKline executive with obstructing justice and making false statements in an effort to conceal illegal promotion of a company drug.


Feds close FDA whistleblower probe

November 10, 2010 9:58 am | News | Comments

For the second time this year, federal inspectors have dismissed allegations by Food and Drug Administration scientists who say they were pressured into approving medical devices.

Promising Target for New Pancreatic Cancer Treatments

November 9, 2010 12:33 pm | News | Comments

Researchers from University of North Carolina Lineberger Comprehensive Cancer Center identified a protein called RGL2 as an attractive target making a KRAS-blocking drug.


Reshaping Basic Understanding of Cell Division

November 9, 2010 12:29 pm | News | Comments

By tracking the flow of information in a cell preparing to split, Johns Hopkins scientists have identified a protein mechanism that coordinates and regulates the dynamics of shape change necessary for division of a single cell into two daughter cells.


XOMA Issued Two New U.S. Patents Covering XOMA 052

November 9, 2010 12:25 pm | News | Comments

XOMA Ltd. announced that the U.S. Patent and Trademark Office today issued two new patents to XOMA as part of the company's expanding intellectual property portfolio around its XOMA 052 antibody to interleukin-1 beta (IL-1 beta).


Trial Compares Epanova to Lovaza

November 9, 2010 12:22 pm | News | Comments

Omthera Pharmaceuticals, Inc. announced the initiation of a randomized, open-label, four-way cross-over pharmacokinetics study to evaluate the bioavailability of Epanova, Omthera’s lead compound for the treatment of very high triglycerides.



November 9, 2010 12:16 pm | Product Releases | Comments

QIAGEN has launched several new products that assist in the molecular analysis of formalin-fixed, paraffin-embedded (FFPE) tissue samples.


CNV Detection

November 9, 2010 12:14 pm | Product Releases | Comments

NanoString Technologies, Inc. launched a novel solution for detecting genetic copy number variations (CNVs) associated with disease susceptibility, drug response, and cancer progression.


Winner of HCA Award Achieved 20-Fold Increase in Throughput

November 9, 2010 12:06 pm | News | Comments

GE Healthcare announced that Dr. Michael Freeley from the Institute of Molecular Medicine, Trinity College Dublin is winner of the first GE Healthcare HCA Award.


Genentech Named 2010 Facility of the Year Awards Winner

November 9, 2010 12:03 pm | News | Comments

ISPE announced that Genentech’s ECP-1 Bacterial Manufacturing Facility is the overall winner of the 2010 Facility of the Year Awards (FOYA) program.


Abbott HIV Test Kits to Clinton Health Access Initiative

November 9, 2010 5:29 am | News | Comments

Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI.


TB Alliance Launches First Clinical Trial

November 9, 2010 5:26 am | News | Comments

The Global Alliance for TB Drug Development (TB Alliance) announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients.


Report: Innovative Drug Strategies Fail to Appear

November 9, 2010 5:22 am | News | Comments

According to a new report released today by Citeline Drug Intelligence, the 240th meeting of the American Chemical Society disappointed expectations with a lack of new drug targets being announced at the event.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.